Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAD51 is an ATP-dependent recombinase essential for homologous recombination-mediated repair of double-strand DNA breaks. It forms a nucleoprotein filament on single-stranded DNA, facilitating homology search and strand invasion. Dysregulation or mutation of RAD51 is associated with cancer and genomic instability disorders, making it a potential therapeutic target.
Inhibition of homologous recombination
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA repair protein RAD51 homolog 1 (RAD51).